These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6016794)

  • 21. Transient vasopressin-resistant diabetes insipidus of pregnancy.
    Barron WM; Cohen LH; Ulland LA; Lassiter WE; Fulghum EM; Emmanouel D; Robertson G; Lindheimer MD
    N Engl J Med; 1984 Feb; 310(7):442-4. PubMed ID: 6694683
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetes mellitus and vasopressin sensitive diabetes insipidus.
    Padrón RS; Amaro S; Licea M; Hung S; González J; Mateo de Acosta O
    Acta Diabetol Lat; 1980; 17(2):179-83. PubMed ID: 7445914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Some indications for the use of vasopressin in diabetes insipidus].
    Jakubowska D; Pedich W
    Pol Tyg Lek; 1966 May; 21(19):721-2. PubMed ID: 5937922
    [No Abstract]   [Full Text] [Related]  

  • 24. [Synthetical vasopressin (Minirin) for treatment of diabetes insipidus].
    Frøyshov Larsen I
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):301. PubMed ID: 7385158
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy.
    Vokes TJ; Gaskill MB; Robertson GL
    Ann Intern Med; 1988 Feb; 108(2):190-5. PubMed ID: 3341651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies.
    Edwards CR; Kitau MJ; Chard T; Besser GM
    Br Med J; 1973 Aug; 3(5876):375-8. PubMed ID: 4581079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion of vasopressin in comatose children with neurogenic diabetes insipidus.
    Lee YJ; Shen EY; Huang FY; Kao HA; Shyur SD
    J Pediatr Endocrinol Metab; 1995; 8(4):257-62. PubMed ID: 8821902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasopressin].
    Murase T; Yoshida T
    Horumon To Rinsho; 1972 Oct; 20(10):805-7. PubMed ID: 4568945
    [No Abstract]   [Full Text] [Related]  

  • 29. [Familial primary vasopressin resistant diabetes insipidus sensitive to biguanide].
    Villamor J; Hita J; Barreiro P; Ortiz Vázquez J; Vãzquez JJ
    Rev Clin Esp; 1971 Apr; 121(1):51-62. PubMed ID: 5563103
    [No Abstract]   [Full Text] [Related]  

  • 30. [Successful substitution therapy of diabetes insipidus centralis in the Hand-Schüller-Christian type of histiocytosis X by using synthetic analogue of vasopressin--DDAVP].
    Némethová V; Sýkora F; Lichardus B
    Bratisl Lek Listy; 1974 Mar; 61(3):366-71. PubMed ID: 4825136
    [No Abstract]   [Full Text] [Related]  

  • 31. [The therapy of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (autor's transl)].
    Novotný P
    Cas Lek Cesk; 1973 Jul; 112(35):1083-4. PubMed ID: 4751289
    [No Abstract]   [Full Text] [Related]  

  • 32. Pituitary rsponsiveness to aqueous vasopressin in patients with congenital vasopressin-resistant diabetes insipidus.
    Sober AJ; Gorden P
    J Clin Endocrinol Metab; 1972 Dec; 35(6):924-5. PubMed ID: 4634492
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chlorpropamide therapy of diabetes insipidus].
    Pabst R; Huchzermeyer H; Kalden J
    Med Klin; 1972 Mar; 67(13):462-5. PubMed ID: 5023231
    [No Abstract]   [Full Text] [Related]  

  • 34. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasopressin in the treatment of diabetes insipidus.
    Hartshorn J; Hartshorn E
    J Neurosci Nurs; 1988 Feb; 20(1):58-9. PubMed ID: 2963876
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical value of the combination of vasopressin and chlorpropamide in a patient with "refractory" diabetes insipidus.
    Radó JP; Szende L; Takó J; Góth E; Fövényi J
    Endokrinologie; 1972 Feb; 59(2):203-12. PubMed ID: 5036075
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary: On the use of pitressin in infants with neurogenic diabetes insipidue.
    Crigler JF
    J Pediatr; 1976 Feb; 88(2):295-6. PubMed ID: 1249693
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of diabetes insipidus with a synthetic arginine-vasopressin analog].
    Oravec D; Lichardus B; Kovác R; Sárkady H; Zaoral M
    Z Gesamte Inn Med; 1972 Nov; 27(22):993-4. PubMed ID: 4649662
    [No Abstract]   [Full Text] [Related]  

  • 39. Chlorpropamide treatment of diabetes insipidus in children.
    Vallet HL; Prasad M; Goldbloom RB
    Pediatrics; 1970 Feb; 45(2):246-53. PubMed ID: 5413386
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.